Cambridge Crystallographic Data Centre (CCDC)

Understanding compound selectivity and pocket druggability with data-driven drug design

This article is brought to you by: 

Selectivity is a crucial property in the development of new active pharmaceutical ingredients (APIs). Binding site comparisons within a protein family are key to understanding how to modulate the selectivity profile of a potential new API, which includes understanding both on- and off-target effects. 

CSD Solid Form Suite

The Cambridge Crystallographic Data Centre (CCDC) has announced CSD Solid Form Suite to support pharmaceutical and agrochemical development

Subscribe to RSS - Cambridge Crystallographic Data Centre (CCDC)